• Zitromax
• Azacid
• Azeptin
• Aziprome
• Azitredil
• Azitroerre
• Azitromicina
• Azitromicina ABC
• Azitromicina Eurogenerici
• Azitrox
• Azylung
• Azyter
• Batif
• Cinetrin
• Macrozit
• Portex
• Rezan
• Ribotrex
• Tetris
• Trozamil
• Trozocina
• Zimacrol
• Zindel
• Zitrobiotic
• Zitrogram

Azitromicina

Zitromax, Ribotrex e altri

Bibliografia - Quali fonti bibliografiche per Azitromicina?

1. Adverse Drug Reaction Bulletin, 2013, n 212, edizione italiana.


2. Albert R.K. et al., NEJM, 2011, 365 (8), 689.


3. Altenburg J. et al., JAMA, 2013, 309 (12), 1251.


4. Amsden G.W. et al., J. Clin. Pharmacol., 2000, 40 (12 Pt 2), 1522.


5. Amsden GW. et al., J. Clin. Pharmacol., 2001, 41 (2), 210.


6. Anagnostopoulos G.K. et al., J. Clin. Gastroenterol., 2003, 36, 325.


7. Apseloff G.A. et al., J. Clin. Pharmacol., 1998, 36, 830.


8. Bergeron A. et al., JAMA, 2017, 318 (6), 557.


9. Cadle R.M. et al., Ann. Pharmacother., 1997, 31, 1308.


10. Cercek B. et al., Lancet, 2003, 361 (9360), 809.


11. Clin Pharmacokinet., 2000, 38 (3), 260.


12. Corriere Medico, 1991, 21-22 Novembre.


13. Curatolo W. et al., Pharm. Res., 2011, 28 (7), 1531.


14. Dietz A. et al., Laryngorhinootologie, 1998, 77 (2), 111.


15. Drug Fut., 2000, 25 (1), 77.


16. Equi A et al., Lancet, 2002, 360, 978.


17. FDA, Safety Announcement, 2013, 12 marzo disponibile on line http://www.fda.gov/Drugs/DrugSafety/ucm341822.htm


18. Foulds G. et al., J. Clin. Pharmacol., 1991, 31, 164 e 859.


19. Gardner M.J. et al., Mediterranean Congress Chemotherapy, maggio 1992, Atene (abst.).


20. Goodman & Gilman, Le Basi Farmacologiche della Terapia, 1997, nona edizione, McGraw-Hill.


21. Gordillo M.E. et al., Antimicrob. Agents Chemother.,1993, 37,1203.


22. Grayston J.T. et al., NEJM, 2005, 352 (16), 1637.


23. Greenblatt D.J. et al., Clin. Pharmacol. Ther., 1998, 64 (3), 278.


24. Grunden J.W. et al., Ann. Pharmacother., 1997, 31, 859.


25. Hamilton-Miller J.M.T., J. Antimicrob. Chemother.,1992,29,141.


26. Hammerschlag M.R. et al., Pediatr. Infect. Dis., 1998, 17, 1049.


27. Handsfield H.H. et al., Sex Trans Dis, 1995, 274, 545.


28. Harris S. et al., Clin. Pharmacol. Ther., 1995, 58 (3), 310.


29. Hooton T.M., Am. J. Med., 1991, 91 Suppl. 3A, 23S.


30. Hubern C. et al., Lancet, 1997, 350, 563.


31. Khosropour C.M. et al., NEJM, 2014, 370 (20), 1961.


32. Kintzel P.E., Ann. Pharmacother., 1998, 32, 388.


33. Lane G. et al., Ann. Pharmacother., 1996, 30, 884.


34. Ljutic G., Rumboldt Z., Nephron, 1995, 70, 130.


35. Loewen P.S. et al., Drugs, 1999, 57, 157.


36. Luke D.R. et al., Antimicrob. Agents Chemother., 1996, 40, 2577.


37. Mansor G.A. et al., Ann. Intern. Med., 1993, 119, 636.


38. Martin D.H. et al., NEJM, 1991, 327, 921.


39. Martindale, The complate drug reference, 1999, 32 ed. Pharmaceutical Press.


40. MMWR Morb. Mortal Wkly Rep., 2013, 62 (6), 103.


41. Muhlestein J.B. et al., Circulation, 2000, 102 (15), 1755.


42. O’Connor C.M. et al., JAMA, 2003, 290 (11), 1459.


43. Pai M.P. et al., Ann. Pharmacother., 2000, 34 (4), 495.


44. Pinto L.A. et al., J. pediatr., 2012, 161 (6), 1104.


45. Pollak P.T. et al., Pharmacotherapy, 1997, 17, 827.


46. Ray W.A. et al., NEJM, 2012, 366 (20), 1881.


47. Salomon A.W. et al , NEJM, 2004, 351, 1962.


48. Scaglione F., Fraschini F., Medico e Paziente, 1990, 11, 84.


49. Svanstrom H. et al., NEJM, 2013, 368, 1704.


50. Ten Eick A.P. et al., Clin. Drug Invest., 2000, 20, 61


51. Thalhammer F. et al., Br. J. Clin. Pharmacol., 1998, 45 (1), 91.


52. The Medical Letter, 1999, 22, 95.


53. The Medical Letter, 2000, 12, 53.


54. Trifirò G. et al., CMAJ, 2017, 189 (15), E560.


55. Wallace M.R. et al., Lancet, 1994, 343, 241.


56. Wright A.J. et al., CMAJ, 2011, 183 (3), 303.


57. Young L.S. et al., Lancet, 1991, 338, 1107.